Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196557 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject
A Phase 1 study of Immunoscience, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT03196557: Completed Phase 1 study of Immunoscience, sponsored by Bristol-Myers Squibb.
NCT03196557 is a Phase 1 study of Immunoscience that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 24 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03196557, a Phase 1 study of Immunoscience, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects
Primary Outcome
As measured by flow cytometry
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Prenisolone
Study Locations (2)
Texas
- Ppd Development - Austin
- Local Institution - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-03-31 |
| Est. Completion | 2008-05-05 |
| Phase | Phase 1 |
What the finished NCT03196557 record still lists
NCT03196557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Immunoscience appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03196557 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03196557 about?
NCT03196557 is a clinical study titled "A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject". The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects
What is the current status of trial NCT03196557?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-03-31. Estimated completion is 2008-05-05.
What conditions does trial NCT03196557 study?
This clinical trial studies the following conditions: Immunoscience.
What interventions are being tested in trial NCT03196557?
The interventions under investigation include: Placebo (DRUG), Prenisolone (DRUG).
Who is sponsoring clinical trial NCT03196557?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03196557 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03196557's enrollment target sits among peer trials
24 1520th of 2000 higher than 405 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI